Salud financiera de hoja de balance de Gufic Biosciences
Salud financiera controles de criterios 4/6
Gufic Biosciences has a total shareholder equity of ₹5.3B and total debt of ₹3.3B, which brings its debt-to-equity ratio to 62.5%. Its total assets and total liabilities are ₹10.9B and ₹5.6B respectively. Gufic Biosciences's EBIT is ₹1.3B making its interest coverage ratio 8.1. It has cash and short-term investments of ₹134.8M.
Información clave
62.5%
Ratio deuda-patrimonio
₹3.33b
Deuda
| Ratio de cobertura de intereses | 8.1x |
| Efectivo | ₹134.84m |
| Patrimonio | ₹5.33b |
| Total pasivo | ₹5.60b |
| Activos totales | ₹10.93b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 509079's short term assets (₹6.0B) exceed its short term liabilities (₹3.7B).
Pasivo a largo plazo: 509079's short term assets (₹6.0B) exceed its long term liabilities (₹1.9B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 509079's net debt to equity ratio (60%) is considered high.
Reducción de la deuda: 509079's debt to equity ratio has reduced from 127.4% to 62.5% over the past 5 years.
Cobertura de la deuda: 509079's operating cash flow is negative, therefore debt is not well covered.
Cobertura de intereses: 509079's interest payments on its debt are well covered by EBIT (8.1x coverage).